Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Extracorporeal or ex vivo removal of antibodies or immune...
Reexamination Certificate
2005-04-19
2005-04-19
Saunders, David (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Extracorporeal or ex vivo removal of antibodies or immune...
C424S139100, C604S005010, C604S005020, C604S005040
Reexamination Certificate
active
06881408
ABSTRACT:
The invention relates to immunoadsorbers for use in sepsis therapy, in particular for removal of complement factors and lipopolysaccharides (LPS) and, if need be, further sepsis mediators such as TNF and interleukins from body fluids, methods for their production and their use.
REFERENCES:
patent: 5626843 (1997-05-01), Surkovich et al.
patent: 5853722 (1998-12-01), Rollins et al.
patent: 6074642 (2000-06-01), Wang et al.
patent: 6193681 (2001-02-01), Davidner et al.
patent: 6287516 (2001-09-01), Matson et al.
patent: WO 9834959 (1998-08-01), None
Hahn Hans-Jürgen
Heinrich Hans-Werner
Kruschke Peter
Meyer Udo
Wagner Heinz-Jürgen
Bioserv AG
Norris McLaughlin & Marcus PA
Saunders David
LandOfFree
Immunoadsorber for use in sepsis therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoadsorber for use in sepsis therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoadsorber for use in sepsis therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3412418